Institutional investors purchased a net $566.2 thousand shares of IMMU during the quarter ended September 2015, and now own 42.65% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 35.0 Thousand shares of Immunomedics Inc
VANGUARD INVESTMENTS AUSTRALIA L... Bought 5.0 Thousand shares of Immunomedics Inc
ZÜRCHER KANTONALBANK (INVESTMENT... Bought 3.4 Thousand shares of Immunomedics Inc